Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Search

Page Path
HOME > Search
1 "Seyed Davar Siadat"
Filter
Filter
Article category
Publication year
Original Article
IBD
Preventive and therapeutic effects of co-administration of Bacteroides thetaiotaomicron and infliximab on dextran sodium sulfate-induced colitis in mice
Sara Ahmadi Badi, Hamid Reza Moradi, Ahmad Berimipour, Shima Shojaie, Arian Kariman, Hananeh Tavakoli Aval, Seyed Amirhesam Seyedi, Mehdi Davari, Mohammad Hassan Sohouli, Shohreh Khatami, Seyed Davar Siadat, Pejman Rohani
Intest Res 2026;24(3):475-491.   Published online December 12, 2025
DOI: https://doi.org/10.5217/ir.2025.00061
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Background/Aims
The gut microbiota plays a crucial role in the pathogenesis and treatment of inflammatory bowel diseases (IBD). This study aimed to investigate the effects of active, heat-inactivated, and cell-free supernatant (CFS) forms of Bacteroides thetaiotaomicron, alone or in combination with infliximab, in dextran sodium sulfate (DSS)-induced colitis in mice. Colitis was induced by oral administration of DSS for seven days. B. thetaiotaomicron in its various forms was orally administered at a dose of 1 × 108 CFU prior to and during colitis induction. Infliximab was intraperitoneally injected from days 3 to 5 of DSS exposure. Colitis severity, gene expression, tumor necrosis factor alpha levels, and gut microbiota were assessed by disease activity index, reverse transcription-quantitative polymerase chain reaction (RT-qPCR), enzyme-linked immunosorbent assay (ELISA), and qPCR, respectively.
Results
Active B. thetaiotaomicron and its CFS form significantly alleviated colitis symptoms compared to the heat-inactivated form. Furthermore, co-administration of active B. thetaiotaomicron and infliximab significantly modulated the colonic mRNA expression of Ocln, Tff3, Muc2 (upregulated), and Ace2 (downregulated). This combination also exhibited synergistic improvement in colitis severity in treated mice.
Conclusions
These findings underscore the therapeutic potential of B. thetaiotaomicron in IBD, either alone or in combination with infliximab, and support further development of microbiota-based strategies for IBD prevention and treatment.

Citations

Citations to this article as recorded by  
  • Early-Life Iron Exposure Influences Long-Term Gut Microbiota Recovery After Intestinal Dysbiosis
    Thibault Maumy, Claire McCartney, Ayodeji Samuel Ajayi, Claire Gerkins, Gabriela Fragoso, Annie Calvé, Manuela M. Santos
    Microorganisms.2026; 14(5): 1105.     CrossRef
  • From Multi-Omics to Molecular Causality: A Five-Tier Evidence Framework for the Single-Bacterium–Metabolite Axis in IBD
    Xingyue Song, Wanting Wang, Jingjing Yang, Xinning Liang, Wanli Ji
    Microorganisms.2026; 14(8): 1744.     CrossRef
  • Probiotic drug interactions in ulcerative colitis: a microbiota and metabolite perspective
    Jana Štofilová, Veronika Benetinová, Izabela Bertková, Zuzana Hanzelová, Anna Kamlárová, Monika Kvaková
    Frontiers in Microbiology.2026;[Epub]     CrossRef
  • Lactational exposure to polystyrene nanoplastics is associated with hepatorenal alterations, oxidative stress, and apoptosis-associated changes in male rat offspring
    Mohsen Rashidi, Hamid Reza Moradi, Zabihollah Khaksar, Sajjad Abbasi
    OpenNano.2026; 32: 100325.     CrossRef
  • 4,765 View
  • 191 Download
  • 3 Web of Science
  • 4 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP